BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27404981)

  • 1. Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.
    Yoder KE; Bundschuh R
    Sci Rep; 2016 Jul; 6():29530. PubMed ID: 27404981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR/Cas9 genome editing.
    Feng Y; Liu S; Chen R; Xie A
    J Zhejiang Univ Sci B; 2021 Jan; 22(1):73-86. PubMed ID: 33448189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
    Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
    Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
    Lebbink RJ; de Jong DC; Wolters F; Kruse EM; van Ham PM; Wiertz EJ; Nijhuis M
    Sci Rep; 2017 Feb; 7():41968. PubMed ID: 28176813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
    Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
    Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
    EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
    Wang G; Zhao N; Berkhout B; Das AT
    Mol Ther; 2016 Mar; 24(3):522-6. PubMed ID: 26796669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection.
    Yin L; Hu S; Mei S; Sun H; Xu F; Li J; Zhu W; Liu X; Zhao F; Zhang D; Cen S; Liang C; Guo F
    Hum Gene Ther; 2018 Nov; 29(11):1264-1276. PubMed ID: 29644868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.
    Dampier W; Sullivan NT; Mell JC; Pirrone V; Ehrlich GD; Chung CH; Allen AG; DeSimone M; Zhong W; Kercher K; Passic S; Williams JW; Szep Z; Khalili K; Jacobson JM; Nonnemacher MR; Wigdahl B
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):950-960. PubMed ID: 29968495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
    Cullot G; Boutin J; Toutain J; Prat F; Pennamen P; Rooryck C; Teichmann M; Rousseau E; Lamrissi-Garcia I; Guyonnet-Duperat V; Bibeyran A; Lalanne M; Prouzet-Mauléon V; Turcq B; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
    Nat Commun; 2019 Mar; 10(1):1136. PubMed ID: 30850590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication.
    Ueda S; Ebina H; Kanemura Y; Misawa N; Koyanagi Y
    Microbiol Immunol; 2016 Jul; 60(7):483-96. PubMed ID: 27278725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans.
    Paix A; Folkmann A; Seydoux G
    Methods; 2017 May; 121-122():86-93. PubMed ID: 28392263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants.
    Dampier W; Sullivan NT; Chung CH; Mell JC; Nonnemacher MR; Wigdahl B
    Sci Rep; 2017 Oct; 7(1):14413. PubMed ID: 29089503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating Mutant for a Stress-Responsive Gene in Rice Using CRISPR-Cas9 System.
    Prakash CS; Sunkar R
    Methods Mol Biol; 2024; 2832():281-290. PubMed ID: 38869803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.